| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |